Skip to content

The users of Novel Psychoactive Substances: Online survey about their characteristics, attitudes and motivations

Christophe Soussan, Anette Kjellgren

International Journal of Drug Policy March 23, 2016 DOI: 10.1016/j.drugpo.2016.03.007 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Cross-sectional online survey Peer reviewed
Sample size 619
Population International users of novel psychoactive substances recruited via bluelight.org
Measures WHO-5 Wellbeing Index
Topics Addiction
Keywords Pleasure Harm reduction Incentive Sample material Public health Psychotherapist
Citations 152
Key findings Pleasure and enjoyment were the main incentives for NPS use overall. Hallucinogen use was motivated by self-exploration and spiritual attainment with low addiction potential, whereas opioid and GABA-acting substance use was motivated by coping with higher addiction potential. Synthetic cannabinoids were least appreciated and used mainly due to availability and legality.

Abstract

Background: The increasing number of Novel Psychoactive Substances (NPS) constitutes a challenge for public health agencies and researchers worldwide. Scientific studies about NPS and their users are limited and there is a need to explore the general motivations for NPS use but also to examine if and how the motivations differ between substances from separate effect classes. The aim of the present study was to investigate the characteristics, including attitudes and motivations, of a self-selected sample of international NPS users.

Methods: An online survey containing questions about drug use history, attitudes, motivations for use, and WHO-5 Wellbeing Index was promoted at the drug discussion forum bluelight.org. The data was analysed using SPSS.

Results: The sample consisted of 619 international NPS users with overall good emotional well-being despite extensive experience of both traditional and novel drugs. The main incentive for use of NPS in general was pleasure and enjoyment. However, going beyond the general approach to NPS revealed significant variations between drug groups. For example, the use of hallucinogens was substantially motivated by self-exploration and spiritual attainment and showed very low levels of addiction potential while the use of opioids and especially GABA activating substances was mainly motivated by coping and showed much higher levels of addiction potential. Synthetic cannabinoids were the least appreciated and least likely to be used again, and were mainly motivated by circumstances such as availability and legality.

Conclusion: Understanding the different motivations for NPS use in terms of drug groups could enable more effective prevention and consequently a reduction in harm.

Comparable studies

Other cross-sectional and survey studies on addiction, most cited first.

Study Year Design Participants
Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey Online survey respondents 2020 Cross-sectional survey
User perceptions of the benefits and harms of hallucinogenic drug use: A web-based questionnaire study Users of hallucinogenic drugs who completed a web-based questionnaire 2010 Cross-sectional survey n = 600
Psychological and neuropsychological assessment of regular hoasca users. Regular hoasca users from a U.S. branch of União do Vegetal and matched non-user controls 2016 Cross-sectional study n = 57
Client and counselor attitudes toward the use of medications for treatment of opioid dependence. Counselors and clients from outpatient, methadone, and residential drug treatment programs 2007 Cross-sectional survey n = 1,459
Neural Correlates of the Severity of Cocaine, Heroin, Alcohol, MDMA and Cannabis Use in Polysubstance Abusers: A Resting-PET Brain Metabolism Study Polysubstance users enrolled in residential treatment 2012 Cross-sectional n = 49

Citations in the library

Explore topics